Medetomidine
- Level
- Commodity
- Parent
- 51392200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51392210This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MR15E85MQM, chemically known as 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)- but generally known as medetomidine, which bears US NIH Compound Identifier 68602. European Medicines Agency schedules Medetomidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08691MIG. The term MEDETOMIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). MEDETOMIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule medetomidine under HS 29332990 and SITC 51573. As of Q4 2014, MEDETOMIDINE remains the US FDA Preferred Term for this commodity. Medetomidine bears US NLM identifiers UMLS ID C0125656 and NCI Concept Code C81367. SMILES: CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.
Same parent
Under 51392200 · 30Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.